|Bid||1.3800 x 1200|
|Ask||1.4500 x 3100|
|Day's Range||1.3500 - 1.4500|
|52 Week Range||0.7700 - 2.0100|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 08, 2023 - Feb 13, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursday, January 18-19, 2023.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
The heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.